June 12, 2024



Gilead announces long-awaited price for Covid-19 drug remdesivir


By Matthew Herper

June 29, 2021

Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians, and Wall Street investors have engaged in a tense guessing game: What would its maker, Gilead Sciences, charge for the drug?

Now there is an answer.

Read more…